Viropro International Inc. (VPRO.OB) is focused on supporting pharmaceutical companies in South America, Asia, Africa and Eastern Europe, by providing them with the opportunity to produce and commercialize therapeutic products of industrial quality at competitive prices within their local area.
The unique business strategy utilized by Viropro is primarily based on the acquisition of exclusive products and intellectual property as well as developing key partnerships with pre-eminent entities on a global scale. To date the company has signed agreements with Immuno Japan Inc., the Biotechnological Research Institute of the National Council of Canada, the Laboratory of Veterinary, and Food Biotechnology of the University of Montreal.
Not only does the company rely on its comprehensive network of strategic partnerships, but it also benefits from the extensive expertise of its own management team led by Dr. Jean-Marie Dupuy, a leading world-recognized immunologist. The President and CEO has held top management positions at a number of prestigious International institutions, and has authored and co-authored more than 240 scientific and medical articles, books and publications.
Let us hear your thoughts: Viropro International Inc. Message Board